Authors: Persiani, S D'Amato, M Makovec, F Arshad, SH Holgate, ST Rovati, LC

Citation: S. Persiani et al., Pharmacokinetics of andolast after administration of single escalating doses by inhalation in mild asthmatic patients, BIOPHARM DR, 22(2), 2001, pp. 73-81

Authors: Lanza, M Makovec, F

Citation: M. Lanza et F. Makovec, Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCKB receptors located on glutamatergic interneurons, N-S ARCH PH, 361(1), 2000, pp. 33-38

Authors: D'Amato, M Makovec, F Rovati, LC

Citation: M. D'Amato et al., CCKA receptors in gastrointestinal disorders - New therapeutic implications, DRUG DEVELOPMENT, 2000, pp. 147-176

Authors: Revel, L Makovec, F

Citation: L. Revel et F. Makovec, Discovery of new CCK2 receptor antagonists. A review of pharmacological studies. Part I: Development of potential therapeutic tools for gastrin-related gastrointestinal diseases, METH FIND E, 21(5), 1999, pp. 375-383

Authors: Cappelli, A Anzini, M Vomero, S Canullo, L Mennuni, L Makovec, F Doucet, E Hamon, M Menziani, MC De Benedetti, PG Bruni, G Romeo, MR Giorgi, G Donati, A

Citation: A. Cappelli et al., Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy ofarylpiperazine derivatives at the central 5-HT3 receptors, J MED CHEM, 42(9), 1999, pp. 1556-1575

Authors: Makovec, F Revel, L Letari, O Mennuni, L Impicciatore, M

Citation: F. Makovec et al., Characterization of antisecretory and antiulcer activity of CR 2945, a newpotent and selective gastrin/CCKB receptor antagonist, EUR J PHARM, 369(1), 1999, pp. 81-90